Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.245,60
-0,09%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Celyad Oncology SA (CYAD) Celyad Oncology SA (CYAD) Notizie

CYAD

Celyad Oncology (CYAD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:CYAD
DataOraFonteTitoloSimboloCompagnia
08/02/202422:01GlobeNewswire Inc.Celyad Oncology announces intention to terminate SEC reporting obligationsEU:CYADCelyad Oncology SA
16/01/202422:01GlobeNewswire Inc.Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookEU:CYADCelyad Oncology SA
20/12/202322:01GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
15/12/202322:01GlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
04/12/202322:01GlobeNewswire Inc.Celyad announces management changeEU:CYADCelyad Oncology SA
01/12/202312:42GlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
21/11/202322:00GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/11/202307:00GlobeNewswire Inc.Celyad Oncology reports third quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
25/09/202322:01GlobeNewswire Inc.Celyad Oncology announces the termination of its American Depository Receipt programEU:CYADCelyad Oncology SA
15/09/202322:01GlobeNewswire Inc.Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
12/09/202322:01GlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
07/09/202322:01GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
04/09/202322:00GlobeNewswire Inc.Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsEU:CYADCelyad Oncology SA
24/08/202322:00GlobeNewswire Inc.Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersEU:CYADCelyad Oncology SA
15/05/202322:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq delisting noticeEU:CYADCelyad Oncology SA
05/05/202307:00GlobeNewswire Inc.Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqEU:CYADCelyad Oncology SA
05/05/202307:00GlobeNewswire Inc.Celyad Oncology reports first quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
24/04/202322:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid priceEU:CYADCelyad Oncology SA
04/04/202322:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq noticeEU:CYADCelyad Oncology SA
24/03/202307:00GlobeNewswire Inc.Celyad Oncology appoints Georges Rawadi as its new CEOEU:CYADCelyad Oncology SA
23/03/202322:01GlobeNewswire Inc.Celyad Oncology reports full year 2022 financial results and recent business highlightsEU:CYADCelyad Oncology SA
17/03/202322:01GlobeNewswire Inc.Celyad Oncology to announce full year 2022 financial results and host conference callEU:CYADCelyad Oncology SA
15/03/202307:00GlobeNewswire Inc.Celyad Oncology announces non-cash impairmentEU:CYADCelyad Oncology SA
01/03/202307:00GlobeNewswire Inc.REPEAT -- Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
28/02/202317:16GlobeNewswire Inc.Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
09/02/202307:00GlobeNewswire Inc.Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01EU:CYADCelyad Oncology SA
03/02/202307:00GlobeNewswire Inc.Celyad Oncology provides fourth quarter 2022 business update and 2023 outlookEU:CYADCelyad Oncology SA
21/12/202207:00GlobeNewswire Inc.Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual propertyEU:CYADCelyad Oncology SA
10/11/202207:01GlobeNewswire Inc.Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business HighlightsEU:CYADCelyad Oncology SA
20/09/202207:00GlobeNewswire Inc.Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations TransactionEU:CYADCelyad Oncology SA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:CYAD

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TRN
Terna Trasmissione Elett...
BIT
LDO
Leonardo
BIT
SRG
Snam
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
TEN
Tenaris
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network